Syndax Pharmaceuticals In... (SNDX)

AI Score

Unlock

12.45

-0.52 (-4.01%)

At close: Apr 03, 2025, 3:59 PM

12.98

4.24%

After-hours: Apr 03, 2025, 07:30 PM EDT

Syndax Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Cash & Equivalents	154.08M	295.39M	74.36M	221.97M	115.24M	24.61M	33.77M	35.17M	23.84M	23.18M	10.01M	10.1M	537K	3.7M
Short-Term Investments	418.8M	282.19M	410.04M	217.97M	177.82M	35.17M	47.14M	94.81M	81.49M	64.11M	2.2M	4.16M	91K	613K
Long-Term Investments	119.52M	29.83M	5.47M	n/a	115K	115K	n/a	3.25M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	217K	680K	9.44M	n/a	1.15M	82K	219K	231K	243K	1.81M	339K	2.48M	755K	345K
Receivables	11.24M	1.23M	4.06M	429K	175K	116K	253K	377K	306K	258K	35K	n/a	n/a	n/a
Inventory	366K	n/a	-4.25M	7.65M	5.28M	1.68M	1.05M	-1.44M	2.41M	264K	51K	n/a	n/a	n/a
Other Current Assets	18.57M	63K	8.79M	7.27M	456K	2.06M	1.79M	1.29M	615K	996K	150K	50K	83K	77K
Total Current Assets	603.06M	580.88M	481.27M	448.4M	298.86M	62.33M	83.35M	133.44M	108.51M	88.01M	12.44M	14.54M	735K	4.39M
Property-Plant & Equipment	2.02M	1.5M	1.06M	1.26M	482K	997K	373K	267K	260K	88K	33K	40K	20K	50K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	121.76M	32M	15.96M	1.26M	1.75M	1.19M	592K	3.74M	503K	1.9M	372K	2.52M	775K	395K
Total Assets	724.82M	612.88M	497.24M	449.66M	300.61M	63.52M	83.94M	137.19M	109.01M	89.9M	12.82M	17.06M	1.51M	4.79M
Account Payables	11.63M	9.96M	4.35M	5.67M	3.51M	6.18M	1.44M	2.23M	2.38M	1.45M	354K	1.08M	776K	810K
Deferred Revenue	n/a	n/a	n/a	12.76M	1.52M	1.52M	1.52M	1.57M	1.22M	1.22M	3.38M	n/a	2.41M	n/a
Short-Term Debt	12.12M	n/a	n/a	n/a	2.29M	n/a	n/a	n/a	n/a	n/a	6.45M	n/a	21.34M	10.68M
Other Current Liabilities	79.33M	35.92M	18.33M	1.89M	8.03M	7.39M	10.35M	9.6M	5.13M	916K	1.94M	n/a	660K	1.92M
Total Current Liabilities	103.55M	58.1M	29.07M	20.68M	18.87M	18.37M	16.11M	15.8M	10.37M	4.85M	10.35M	2.73M	25.1M	13.41M
Long-Term Debt	n/a	n/a	n/a	19.89M	17.83M	n/a	n/a	n/a	n/a	n/a	7.43M	n/a	n/a	8.66M
Other Long-Term Liabilities	228.02M	n/a	n/a	n/a	1K	5K	136K	310K	288K	2.92M	751K	2.48M	5.69M	1.77M
Total Long-Term Liabilities	229.59M	588K	722K	20.61M	29.55M	13.56M	14.79M	17.07M	14.51M	18.36M	8.19M	2.48M	5.69M	10.44M
Total Liabilities	436.69M	58.68M	29.79M	41.29M	48.42M	31.93M	30.89M	32.87M	24.87M	23.2M	18.53M	5.21M	30.8M	23.84M
Total Debt	12.12M	1.64M	1.16M	20.97M	20.54M	897K	n/a	n/a	n/a	n/a	13.88M	n/a	21.34M	19.34M
Common Stock	9K	8K	7K	6K	5K	3K	2K	2K	2K	1K	1K	1K	n/a	n/a
Retained Earnings	-1.22B	-902.4M	-693.04M	-543.7M	-568.63M	-495.47M	-439.42M	-366.11M	-305.29M	-259.68M	-159.8M	-135.71M	-79.05M	-68.9M
Comprehensive Income	163K	218K	-806K	45K	-4K	n/a	-25K	-143K	56K	28K	-185K	-170K	-238K	n/a
Shareholders Equity	288.12M	554.2M	467.45M	408.37M	252.19M	31.6M	53.05M	104.32M	84.14M	66.7M	-5.72M	11.85M	-29.29M	-19.05M
Total Investments	538.32M	312.02M	406.92M	217.97M	177.82M	35.17M	47.14M	98.05M	81.49M	64.11M	2.2M	4.16M	91K	613K